The potential benefits of such large scale screening on neuroticism also would need to be balanced against the numbers of false positives, however. That is, if even if the threshold for the screen was carefully set, any foreseeable screen will identify some persons who screen high on neuroticism but are not actually at high risk for any adverse outcome. This is an issue of concern because persons who are incorrectly identified as being at high risk for serious physical or medical disorders using measures of neuroticism could experience unnecessary worry and subject an already over-burdened health care system to unnecessary expense. In addition, the use of neuroticism scales as a screening measure could tend to stigmatize diversity in this dimension of normal personality.
